In recognition of National Diabetes Awareness, The Daily Transcript looks at how local companies are finding ways to combat diabetes. Contact us at contact@sddt.com to get more involved.

< previous 1 2 3 4 more stories >

Diabetes surge hits every nation

BRUSSELS, BELGIUM -- One in 10 of the world's population will have diabetes by 2035, according to the International Diabetes Federation. The latest edition of IDF Diabetes Atlas, published Thursday on World Diabetes Day, estimates that people living with diabetes will surge from 382 million to 592 million people by 2035, many in low- and middle-income countries and the majority under age 60. This surge will form the backdrop of the World Diabetes Congress in Melbourne, Australia, this December.

Tandem Diabetes Care shares jump in market debut

Shares of Tandem Diabetes Care Inc. soared in their first day of trading as a public company.

DexCom climbs on strong 3Q sales, outlook

Shares of DexCom jumped Thursday after the medical device maker's third-quarter sales surpassed Wall Street forecasts.

Lilly Tops Analysts’ Estimates on Rising Diabetes Drug Sales

Oct. 23 (Bloomberg) -- Eli Lilly & Co., which may introduce five new drugs next year, reported third-quarter profit that beat analysts’ estimates on cost cuts and higher sales of diabetes products.

Elcelyx Therapeutics completes diabetes study

San Diego-based Elcelyx Therapeutics has completed a 12-week Phase 2b study of NewMet, a delayed-release formulation of metformin for the treatment of patients with type 2 diabetes.

Kaiser Permanente awarded certification in in-patient diabetes care

Kaiser Permanente San Diego has earned The Joint Commission's Gold Seal of Approval for its inpatient diabetes care program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care.

Lexicon surges on diabetes drug study data

NEW YORK (AP) -- Shares of Lexicon Pharmaceuticals surged Tuesday after the company reported successful trial results for a diabetes drug intended for patients with kidney impairment.

Medtronic’s Artificial Pancreas Approved for U.S. Diabetics

Sept. 27 (Bloomberg) -- Medtronic Inc. the world’s largest maker of heart-rhythm devices, won U.S. regulatory approval for the first artificial pancreas that shuts itself off when a patient’s blood sugar levels get dangerously low.

Chinese ‘Catastrophe’ Afflicts 114 Million as Diabetes Spreads

Sept. 4 (Bloomberg) -- China’s diabetes epidemic is worse than previously estimated -- much worse.

Genalyte, Barbara Davis Diabetes Center to collaborate on diabetes detection

Genalyte Inc. has announced it is collaborating with the Barbara Davis Center for Childhood Diabetes at the University of Colorado School of Medicine to further develop and test multiplexed antigen panels for the early detection of Type 1 diabetes.

MannKind's Afrezza fares well in late-stage trials

VALENCIA, Calif. (AP) -- Drug developer MannKind says its inhaled insulin Afrezza met the main goals behind two late-stage studies involving patients with two types of diabetes.

FDA cracks down on illegal diabetes remedies

WASHINGTON (AP) -- The Food and Drug Administration is cracking down on more than a dozen companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription drugs sold online without a prescription.

< previous 1 2 3 4 more stories >

Newsmaker videos

John Gomez, Trial Attorney

John Gomez chats about his law firm and why they are different from other San Diego personal injury law firms.

Subscribe Today!